Motor vehicle accidents: How should cirrhotic patients be managed
Motor vehicle accidents (MVAs) are serious social issues worldwide and driver illness is an important cause of MVAs. Minimal hepatic encephalopathy (MHE) is a com- plex cognitive dysfunction with attention deficit, which frequently occurs in cirrhotic patients independent of severity of liver diseas...
Gespeichert in:
Veröffentlicht in: | World journal of gastroenterology : WJG 2012-06, Vol.18 (21), p.2597-2599 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2599 |
---|---|
container_issue | 21 |
container_start_page | 2597 |
container_title | World journal of gastroenterology : WJG |
container_volume | 18 |
creator | Kawaguchi, Takumi Taniguchi, Eitaro Sata, Michio |
description | Motor vehicle accidents (MVAs) are serious social issues worldwide and driver illness is an important cause of MVAs. Minimal hepatic encephalopathy (MHE) is a com- plex cognitive dysfunction with attention deficit, which frequently occurs in cirrhotic patients independent of severity of liver disease. Although MHE is known as a risk factor for MVAs, the impact of diagnosis and treatment of MHE on MVA-related societal costs is largely unknown. Recently, Bajaj et al demonstrated valuable findings that the diagnosis of MHE by rapid screening using the inhibitory control test (ICT), and subsequent treatment with lactulose could substantially reduce the societal costs by preventing MVAs. Besides the ICT and lactulose, there are various diagnostic tools and therapeutic strategies for MHE. In this commentary, we discussed a current issue of diagnostic tools for MHE, including neuropsychological tests. We also discussed the advantages of the other therapeutic strategies for MHE, such as intake of a regular breakfast and coffee, and supplementation with zinc and branched chain amino acids, on the MVA-related societal costs. |
doi_str_mv | 10.3748/wjg.v18.i21.2597 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3369995</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>42326934</cqvip_id><sourcerecordid>1020187369</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-ad6ee92272d3e32c0b7a8fbb0d668b0c7a742725285545e75bd9d316b7425cdb3</originalsourceid><addsrcrecordid>eNpVkM9qGzEQh0VpaBy3957K9pbLOtJotVpdCsU0TcEhl-Qs9M-7CuuVLa0d-ip9lrxTXyEydkxyGpj55jfDh9BXgmeUV83V02M725Fm5oHMgAn-AU0AiCihqfBHNCEY81JQ4OfoIqVHjIFSBp_QOUAtMK75BM1vwxhisXOdN70rlDHeumFM_5__FTfhqUhd2Pa2MD7GLozeFGs1-j1QaFes1KBaZz-js6Xqk_tyrFP0cP3rfn5TLu5-_5n_XJSmAhhLZWvnBAAHSx0FgzVXzVJrbOu60dhwxas8ZNAwVjHHmbbCUlLr3GbGajpFPw65661eOWvyG1H1ch39SsW_Migv308G38k27CSltRCC5YDLY0AMm61Lo1z5ZFzfq8GFbZIEAyYNz3RG8QE1MaQU3fJ0hmC5dy-ze5ndy-xe7t3nlW9v3zstvMrOwPdjZheGduOH9sRUQDNFK_oCFqeOfQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1020187369</pqid></control><display><type>article</type><title>Motor vehicle accidents: How should cirrhotic patients be managed</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Kawaguchi, Takumi ; Taniguchi, Eitaro ; Sata, Michio</creator><creatorcontrib>Kawaguchi, Takumi ; Taniguchi, Eitaro ; Sata, Michio</creatorcontrib><description>Motor vehicle accidents (MVAs) are serious social issues worldwide and driver illness is an important cause of MVAs. Minimal hepatic encephalopathy (MHE) is a com- plex cognitive dysfunction with attention deficit, which frequently occurs in cirrhotic patients independent of severity of liver disease. Although MHE is known as a risk factor for MVAs, the impact of diagnosis and treatment of MHE on MVA-related societal costs is largely unknown. Recently, Bajaj et al demonstrated valuable findings that the diagnosis of MHE by rapid screening using the inhibitory control test (ICT), and subsequent treatment with lactulose could substantially reduce the societal costs by preventing MVAs. Besides the ICT and lactulose, there are various diagnostic tools and therapeutic strategies for MHE. In this commentary, we discussed a current issue of diagnostic tools for MHE, including neuropsychological tests. We also discussed the advantages of the other therapeutic strategies for MHE, such as intake of a regular breakfast and coffee, and supplementation with zinc and branched chain amino acids, on the MVA-related societal costs.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v18.i21.2597</identifier><identifier>PMID: 22690067</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Co., Limited</publisher><subject>Accidents, Traffic - prevention & control ; Algorithms ; Amino Acids, Branched-Chain - therapeutic use ; Coffee ; Cognition ; Cognition Disorders - therapy ; Fibrosis - complications ; Fibrosis - therapy ; Field of Vision ; Hepatic Encephalopathy - complications ; Hepatic Encephalopathy - diagnosis ; Humans ; Lactulose - therapeutic use ; Neuropsychological Tests ; Psychometrics ; Risk Factors ; Treatment Outcome ; Wounds and Injuries - prevention & control ; Zinc - therapeutic use ; 交通事故 ; 机动车 ; 电信增值服务 ; 移动增值业务 ; 管理 ; 肝硬化 ; 认知功能障碍 ; 诊断工具</subject><ispartof>World journal of gastroenterology : WJG, 2012-06, Vol.18 (21), p.2597-2599</ispartof><rights>2012 Baishideng Publishing Group Co., Limited. All rights reserved. 2012</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-ad6ee92272d3e32c0b7a8fbb0d668b0c7a742725285545e75bd9d316b7425cdb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369995/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369995/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22690067$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawaguchi, Takumi</creatorcontrib><creatorcontrib>Taniguchi, Eitaro</creatorcontrib><creatorcontrib>Sata, Michio</creatorcontrib><title>Motor vehicle accidents: How should cirrhotic patients be managed</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>Motor vehicle accidents (MVAs) are serious social issues worldwide and driver illness is an important cause of MVAs. Minimal hepatic encephalopathy (MHE) is a com- plex cognitive dysfunction with attention deficit, which frequently occurs in cirrhotic patients independent of severity of liver disease. Although MHE is known as a risk factor for MVAs, the impact of diagnosis and treatment of MHE on MVA-related societal costs is largely unknown. Recently, Bajaj et al demonstrated valuable findings that the diagnosis of MHE by rapid screening using the inhibitory control test (ICT), and subsequent treatment with lactulose could substantially reduce the societal costs by preventing MVAs. Besides the ICT and lactulose, there are various diagnostic tools and therapeutic strategies for MHE. In this commentary, we discussed a current issue of diagnostic tools for MHE, including neuropsychological tests. We also discussed the advantages of the other therapeutic strategies for MHE, such as intake of a regular breakfast and coffee, and supplementation with zinc and branched chain amino acids, on the MVA-related societal costs.</description><subject>Accidents, Traffic - prevention & control</subject><subject>Algorithms</subject><subject>Amino Acids, Branched-Chain - therapeutic use</subject><subject>Coffee</subject><subject>Cognition</subject><subject>Cognition Disorders - therapy</subject><subject>Fibrosis - complications</subject><subject>Fibrosis - therapy</subject><subject>Field of Vision</subject><subject>Hepatic Encephalopathy - complications</subject><subject>Hepatic Encephalopathy - diagnosis</subject><subject>Humans</subject><subject>Lactulose - therapeutic use</subject><subject>Neuropsychological Tests</subject><subject>Psychometrics</subject><subject>Risk Factors</subject><subject>Treatment Outcome</subject><subject>Wounds and Injuries - prevention & control</subject><subject>Zinc - therapeutic use</subject><subject>交通事故</subject><subject>机动车</subject><subject>电信增值服务</subject><subject>移动增值业务</subject><subject>管理</subject><subject>肝硬化</subject><subject>认知功能障碍</subject><subject>诊断工具</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM9qGzEQh0VpaBy3957K9pbLOtJotVpdCsU0TcEhl-Qs9M-7CuuVLa0d-ip9lrxTXyEydkxyGpj55jfDh9BXgmeUV83V02M725Fm5oHMgAn-AU0AiCihqfBHNCEY81JQ4OfoIqVHjIFSBp_QOUAtMK75BM1vwxhisXOdN70rlDHeumFM_5__FTfhqUhd2Pa2MD7GLozeFGs1-j1QaFes1KBaZz-js6Xqk_tyrFP0cP3rfn5TLu5-_5n_XJSmAhhLZWvnBAAHSx0FgzVXzVJrbOu60dhwxas8ZNAwVjHHmbbCUlLr3GbGajpFPw65661eOWvyG1H1ch39SsW_Migv308G38k27CSltRCC5YDLY0AMm61Lo1z5ZFzfq8GFbZIEAyYNz3RG8QE1MaQU3fJ0hmC5dy-ze5ndy-xe7t3nlW9v3zstvMrOwPdjZheGduOH9sRUQDNFK_oCFqeOfQ</recordid><startdate>20120607</startdate><enddate>20120607</enddate><creator>Kawaguchi, Takumi</creator><creator>Taniguchi, Eitaro</creator><creator>Sata, Michio</creator><general>Baishideng Publishing Group Co., Limited</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20120607</creationdate><title>Motor vehicle accidents: How should cirrhotic patients be managed</title><author>Kawaguchi, Takumi ; Taniguchi, Eitaro ; Sata, Michio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-ad6ee92272d3e32c0b7a8fbb0d668b0c7a742725285545e75bd9d316b7425cdb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Accidents, Traffic - prevention & control</topic><topic>Algorithms</topic><topic>Amino Acids, Branched-Chain - therapeutic use</topic><topic>Coffee</topic><topic>Cognition</topic><topic>Cognition Disorders - therapy</topic><topic>Fibrosis - complications</topic><topic>Fibrosis - therapy</topic><topic>Field of Vision</topic><topic>Hepatic Encephalopathy - complications</topic><topic>Hepatic Encephalopathy - diagnosis</topic><topic>Humans</topic><topic>Lactulose - therapeutic use</topic><topic>Neuropsychological Tests</topic><topic>Psychometrics</topic><topic>Risk Factors</topic><topic>Treatment Outcome</topic><topic>Wounds and Injuries - prevention & control</topic><topic>Zinc - therapeutic use</topic><topic>交通事故</topic><topic>机动车</topic><topic>电信增值服务</topic><topic>移动增值业务</topic><topic>管理</topic><topic>肝硬化</topic><topic>认知功能障碍</topic><topic>诊断工具</topic><toplevel>online_resources</toplevel><creatorcontrib>Kawaguchi, Takumi</creatorcontrib><creatorcontrib>Taniguchi, Eitaro</creatorcontrib><creatorcontrib>Sata, Michio</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawaguchi, Takumi</au><au>Taniguchi, Eitaro</au><au>Sata, Michio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Motor vehicle accidents: How should cirrhotic patients be managed</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2012-06-07</date><risdate>2012</risdate><volume>18</volume><issue>21</issue><spage>2597</spage><epage>2599</epage><pages>2597-2599</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>Motor vehicle accidents (MVAs) are serious social issues worldwide and driver illness is an important cause of MVAs. Minimal hepatic encephalopathy (MHE) is a com- plex cognitive dysfunction with attention deficit, which frequently occurs in cirrhotic patients independent of severity of liver disease. Although MHE is known as a risk factor for MVAs, the impact of diagnosis and treatment of MHE on MVA-related societal costs is largely unknown. Recently, Bajaj et al demonstrated valuable findings that the diagnosis of MHE by rapid screening using the inhibitory control test (ICT), and subsequent treatment with lactulose could substantially reduce the societal costs by preventing MVAs. Besides the ICT and lactulose, there are various diagnostic tools and therapeutic strategies for MHE. In this commentary, we discussed a current issue of diagnostic tools for MHE, including neuropsychological tests. We also discussed the advantages of the other therapeutic strategies for MHE, such as intake of a regular breakfast and coffee, and supplementation with zinc and branched chain amino acids, on the MVA-related societal costs.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Co., Limited</pub><pmid>22690067</pmid><doi>10.3748/wjg.v18.i21.2597</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1007-9327 |
ispartof | World journal of gastroenterology : WJG, 2012-06, Vol.18 (21), p.2597-2599 |
issn | 1007-9327 2219-2840 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3369995 |
source | MEDLINE; Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Accidents, Traffic - prevention & control Algorithms Amino Acids, Branched-Chain - therapeutic use Coffee Cognition Cognition Disorders - therapy Fibrosis - complications Fibrosis - therapy Field of Vision Hepatic Encephalopathy - complications Hepatic Encephalopathy - diagnosis Humans Lactulose - therapeutic use Neuropsychological Tests Psychometrics Risk Factors Treatment Outcome Wounds and Injuries - prevention & control Zinc - therapeutic use 交通事故 机动车 电信增值服务 移动增值业务 管理 肝硬化 认知功能障碍 诊断工具 |
title | Motor vehicle accidents: How should cirrhotic patients be managed |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A11%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Motor%20vehicle%20accidents%EF%BC%9A%20How%20should%20cirrhotic%20patients%20be%20managed&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Kawaguchi,%20Takumi&rft.date=2012-06-07&rft.volume=18&rft.issue=21&rft.spage=2597&rft.epage=2599&rft.pages=2597-2599&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v18.i21.2597&rft_dat=%3Cproquest_pubme%3E1020187369%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1020187369&rft_id=info:pmid/22690067&rft_cqvip_id=42326934&rfr_iscdi=true |